When was Transpact founded?

Transpact was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Transpact located?

Transpact is headquartered in Mumbai, India. It is registered at 204 2ND FLOOR, TIMMY ARCADE, MAKWANA ROAD MAROL, ANDHERI EAST, Mumbai City, MUMBAI, Maharashtra, India, 400059.

Who is the current CEO of Transpact?

Mohammed Aslam Qudratullah Khan of Transpact.

Which legal entities is Transpact associated with?

Transpact is associated with TRANSPACT ENTERPRISES LIMITED and 1 other.

How many employees does Transpact have?

As of Aug 31, 2026, the latest employee count at Transpact is 6.

Is Transpact a funded company?

Transpact is a funded company, having raised a total of $241K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 14, 2015.

When was the latest funding round of Transpact?

Transpact's latest funding was a $***** Seed round on Aug 31, 2019, with participation from 10 investors. Its primary sector is Neurology. Globally, the Neurology sector has seen $5.94B in funding in 2026 to date.

What is the annual revenue of Transpact?

Annual revenue of Transpact is less than ₹10 Cr as on Mar 31, 2025

Where does Transpact rank among its competitors?

Transpact ranks 12th amongst 113 active competitors, of which 22 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Precision Neuroscience, which secured $250M in Sep, 2026.

Who are the top competitors of Transpact?

Transpact's top competitors include Nexstim, Precision Neuroscience and g.tec. Among them, Precision Neuroscience secured the most recent funding round in September, 2026.

Transpact - 2026 Company Profile, Team, Funding, Competitors & Financials

Transpact is a public company based in Mumbai (India), founded in 2013 by Mohammed Aslam Qudratullah Khan. It operates as a Developer of a therapeutic device to stimulate the vestibular system. Transpact has raised $241K in funding from Octaware Technologies and SINE. The company has 113 active competitors, including 22 funded and 13 that have exited. Its top competitors include companies like Nexstim, Precision Neuroscience and g.tec.

Company Details

Developer of a therapeutic device to stimulate the vestibular system. The company's products include a Vestibulator Chair a therapy device for at-home therapy of children suffering from vestibular dysfunction and developmental disorders, and Vestibulator provides stimulations for neuro-developmental and sensory integration therapy. Also, it offers cloud-based therapy and rehabilitation software solutions.

Website: transpact.in
Social
Email ID: *****@transpact.in
Phone Number: +91 **********
Registered Address: 204 2ND FLOOR, TIMMY ARCADE, MAKWANA ROAD MAROL, ANDHERI EAST, Mumbai City, MUMBAI, Maharashtra, India, 400059

Key Metrics

Founded Year

2013

Location

Mumbai, India

Stage

Public

Total Funding

$241K in 4 rounds

Latest Funding Round

Seed, Aug 31, 2019, $*****

Investors

Octaware Technologies & 72 more

Ranked

12^th among 113 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

6 as on Aug 31, 2026

Similar Companies

Nexstim & 128 more

Exit Details

Public

View Transpact's full profile

Transpact is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TRANSPACT MEDTECH PRIVATE LIMITED CIN: U86904MH2023PTC403595 , India, Active	May 26, 2023	0 - ₹10 Cr (As on Mar 31, 2025)	-
TRANSPACT ENTERPRISES LIMITED CIN: U66110MH2013PLC243247 , India, Active	May 12, 2013	0 - ₹10 Cr (As on Mar 31, 2025)	-

Transpact got listed on Sep 05, 2019.

Click here to take a look at Transpact's IPO in detail

Transpact has raised a total funding of $241K over 4 rounds. Its first funding round was on Nov 14, 2015. Its latest funding round was a Seed round on Aug 31, 2019 for $*****. 10 investors participated in its latest round. Transpact has 4 institutional investors and 69 angel investors.

Here is the list of recent funding rounds of Transpact:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 31, 2019	4736232	Seed	7777908	2526041	4444994	7473694
Dec 26, 2017	6113708	Seed	6580224	6961595	8324204	8513370
Feb 25, 2016	8888926	Seed	5529207	7129422	Adam Mahmood Thakur & 1 more	SINE

Access funding benchmarks and valuations. Sign up today!

View details of Transpact's funding rounds and investors

The founders of Transpact is Mohammed Aslam Qudratullah Khan.

Here are the details of Transpact's key team members:

Mohammed Aslam Qudratullah Khan: Co-Founder & CEO of Transpact and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

Transpact's Board of Directors

Transpact's board has 5 active members. Mohammed Aslam Qudratullah Khan and Anis Choudhery are part of team and Moiz Mohsin Miyajiwala, Soummya Sudhir Bania and Shariq Nisar are independent board members.

Here is the list of Transpact's board of directors:

Name	Type	Representing	Status	Duration
Mohammed Aslam Qudratullah Khan	Team	-	Current	13y 4m
ktrnivq	Team	-	Past	3y 8m
xozvhsl	Team	-	Past	3y 4m
bxqflut	Independent board member	-	Past	3y 7m
ltxcbhc	Independent board member	-	Past	3y 3m
kmdorku	Independent board member	-	Past	2y 7m

View details of Transpact's Founder profiles and Board Members

Transpact's employee count trend

Transpact has 6 employees as of Aug 26. Here is Transpact's employee count trend over the years:

Uncover Transpact's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Transpact include Nexstim, Precision Neuroscience and g.tec. Here is the list of Top 10 competitors of Transpact, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nexstim 2000, Helsinki (Finland), Public	Provider of noninvasive brain stimulation for rehabilitating stroke patients	$29.7M	Kreos Capital, Lundbeck Foundation & 9 others	67/100
2nd	Precision Neuroscience 2021, New York City (United States), Series D	Developed of brain-computer interface tool for medical treatment and drug development	$433M	PERSHING SQUARE, Ackman Oxman Institute & 18 others	65/100
3rd	g.tec 1999, Schiedlberg (Austria), Funding Raised	Provider of high-performance brain-computer interfaces and neurotechnologies for invasive and non-invasive recordings	-	EIC Fund, Europa	51/100
4th	Helius Medical 2014, Newtown Square (United States), Public	Developer of neurological rehabilitation medical devices	$391K	Pantera Capital, Summer Capital Management Company ... & 14 others	50/100
5th	Blackrock Neurotech 2008, Salt Lake City (United States), Acquired	Developer of medical devices for neurological therapies	$22.4M	re.Mind Capital, Cavendish Privateers & 12 others	50/100
6th	LIFESCAPES 2018, Minato City (Japan), Series A	Developer of brain-machine interface devices for neurorehabilitation	$3.74M	Beyond Next Ventures, Shionogi & 9 others	50/100
7th	Synergia Medical 2013, Mont Saint Guibert (Belgium), Series B	Developer of an active implantable neurostimulator and contact-less patient monitoring system	$14.2M	Newton Biocapital, SFPI & 8 others	47/100
8th	Minnetronix Medical 1996, Saint Paul (United States), Acquired	Manufacturer of multiple devices for neurocritical patients	$20M	Altaris, NIH & 1 others	46/100
9th	Endonovo Therapeutics 2011, Los Angeles (United States), Public	Bioelectronic devices and therapies for regenerative medicine	-	Kodiak Capital, Azure Capital Partners & 2 others	46/100
10th	BIONIK 2010, Toronto (Canada), Public	Provider of assistive and rehabilitation hardware and software solutions	-	Ginger Capital, MBX Capital & 3 others	45/100
12th	Transpact 2013, Mumbai (India), Public	Developer of a therapeutic device to stimulate the vestibular system	$241K	SINE, Aryaman & 71 others	42/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Transpact's competitors? Click here to see the top ones

Founders (largest shareholder) own 52.90%, Funds own 1.00%, Enterprises own 13.37% and Angels own 28.52%. The net worth of Transpact's founders is INR 2.66Cr as of Aug 31, 2019.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	52.90%	2.66Cr	4241399	3027928	9811599	9599335
Mohammed Aslam Qudratullah Khan	4036378	5138242	8592566	9511329	1830891	5666803
Fund	1.00%	5.02L	0	0	0	0
SINE	0	0	0	0	0	0
Enterprise	13.37%	67.2L	4419583	2560037	9239049	1605300
Angel	28.52%	1.43Cr	5293329	1675239	4788741	9204430
Sultan Abdul Kader	48	63	79	54	23	19
Adam Mahmood Thakur	0	0	0	0	0	0
Other People	4.21%	21.2L	1303	7715	7556	1643
Total	100.00%	5.03Cr	5258638	4460155	3885227	1271747